Introduction
The experimental approach of transfecting oncogenes or proto-oncogenes into cells is widely used to investigate the eects of over-expression on cell phenotype. While similar signal transduction pathways involving many oncogenes are found in most cell types, it is becoming clear the signals generated may induce widely diering responses, from mitosis to apoptosis or dierentiation. The responses can be in¯uenced by several factors, among which the cell phenotype and the strength of the signal generated are important.
Where the signals may generate negative as well as positive eects on cell growth, the clones selected from transfections of constitutively expressed genes will not re¯ect any major growth inhibitory eects of the transfected genes. A more satisfactory approach to examining the multiple eects which an expressed gene may have on cell behaviour is therefore to use a construct where either expression or function of the gene can be regulated after isolation of the transfected clones. We have therefore taken this approach to studying the eects of signalling from the c-erbB2 homodimer in human mammary epithelial cells.
The c-erbB2 receptor is overexpressed in a proportion of breast cancers and over-expression is associated with a poor prognosis (De Potter and Schelfhout, 1995) . c-erbB2 is a tyrosine kinase receptor of the epidermal growth factor (EGF) receptor family which is normally involved in the transduction of signals induced by growth factors such as EGF, heregulin and others. This occurs through heterodimerization with other members of the EGF receptor family, (Alroy and Yarden, 1997) . Upon ligand binding, c-erbB2 heterodimerizes with other members of the EGF receptor family, leading to tyrosine phosphorylation of the receptor subunits' cytoplasmic domains. Homodimerization of c-erbB2, which also leads to tyrosine phosphorylation, is not induced by ligands but is thought to occur in carcinoma cells overexpressing cerbB2.
To study the in¯uence of c-erbB2 overexpression in luminal mammary epithelial cells (the cells from which breast cancers develop), the non-malignant mammary epithelial cell line MTSV1-7 originally derived from cells cultured from human milk, has been used (D'Souza et al., 1993; D'Souza and Taylor-Papadimitriou, 1994) . In these experiments, transfected clones showing constitutive expression and activation of the cerbB2 receptor showed varying degrees of inhibition of expression of epithelial speci®c markers, with very high expression of c-erbB2 inducing complete epithelialmesenchymal conversion, an event found to be induced by other oncogenes (Oft et al., 1996) . Concomitant with the downregulation of expression of epithelial speci®c markers such as E-cadherin, the a 2 integrin subunit was also downregulated in the c-erbB2 transfectants. While this integrin is widely expressed in mesenchymal as well as epithelial cells, its function in the major collagen binding integrin a 2 b 1 in mammary epithelial cells gives it an important role in the interaction of the cells with the extracellular matrix. Furthermore, expression of the a 2 subunit is reduced in some primary breast cancers (Berdichevsky et al., 1994b; Zutter et al., 1993) . This event, aecting cell ± matrix interactions, may play a role in the initiation of metastasis by allowing the cancer cells to detach, invade and proliferate. However, for this to happen, the cells also have to acquire the ability to proliferate without the attachment to the extracellular matrix, which is necessary for the survival of normal epithelial cells (Frisch and Francis, 1994) . The order of events is therefore crucial in determining the survival of the cells proceeding toward outright malignancy.
To examine the sequence of events occurring when cerbB2 is overexpressed in human mammary epithelial cells, and to be able to follow eects which may negatively aect cell growth, we have used the`trk-neu' hybrid receptor (Sachs et al., 1996) . In this construct the extracellular domain of the trkA nerve growth factor (NGF) receptor is fused to the transmembrane and cytoplasmic domains of c-erbB2, thus allowing NGF to act as a ligand, inducing homodimerization of the c-erbB2 cytoplasmic domain in transfected cells. We have transfected the trk-neu hybrid into MTSV1-7 cells and also into HB2 cells (a subclone of MTSV1-7 cells which display a uniformly spherical colony morphology in collagen). Studies with these transfectants have shown that signalling from the c-erbB2 homodimer can confer a growth advantage or impair cell proliferation, depending on the level of expression of the receptor. Thus short term treatment with NGF of cells in collagen resulted in growth stimulation in transfectants expressing low levels of receptor, while the growth of high expressing clones was inhibited. Signi®cantly, the growth inhibition could be reversed by activation of the function of the a 2 b 1 integrin, although the levels of integrin expressed were not aected. Longer term treatment of the high expressing cells with NGF however did lead to a marked reduction in the level of expression of the a 2 integrin subunit, concomitant with a conversion to a mesenchymal phenotype, loss of expression of E-cadherin and impairment of growth potential which was not reversible with integrin activating antibodies. Transfectants were generated by co-transfection of the pBATtrk-neu and pBABEpuro plasmids (tnp clones) or by transfection with the pcDNA3.1zeo/trk-neu plasmid (tnz clones) using calcium phosphate precipitation. Mixtures of puromycin-resistant clones obtained from transfection with the pBABEpuro plasmid (HB2/ puro mix and MTSV1-7/puro mix) were used as control transfectants. In the selected transfectant clones MTSV1-7/tnp20, HB2/tnp26, and HB2/tnp38 and HB2/tnz34, the trk-neu hybrid could be detected at the expected 160-kDa position in Western blot using the 21N antiserum against an epitope in the cytoplasmic domain of c-erbB2 (Figure 1a) . It is evident from this blot that the trk-neu hybrid was expressed at widely dierent levels in the transfectant clones. As shown in Figure 1b , brief (15-min) NGF treatment of the transfectants led to increased tyrosine phosphorylation in of a band coinciding in size with the transfected hybrid receptor, whereas control transfectants showed no response to NGF. In addition to the inducible phosphorylation of trk-neu, a signi®cant level of baseline phosphorylation also occurred, presumably as a result of spontaneous homodimerization. The appearance of more than one band in this region is presumably a result of dierences in mobility induced by dierent degrees of phosphorylation.
Results

Generation of trk-neu transfectant clones
NGF-induced changes in morphology, proliferation and apoptosis of trk-neu transfectant clones
In the short term, all trk-neu transfectants maintained an epithelial morphology when grown on tissue culture plastic, even after treatment with NGF for 1 week (after several passages in the presence of NGF, however, changes in the morphology of the highexpressing HB2/tnz34 and MTSV1-7/tnp20 clones were seen, as will be discussed below). When grown for 1 week in collagen, all trk-neu-expressing clones exhibited a morphological response to NGF (Figure 2a) . In contrast to the low-expressing clone HB2/tnp26, which displayed increased colony size without other morphological changes upon NGF treatment, the other, more high-expressing clones showed varying degrees of NGF-induced cell scattering (quantitated in Figure 2b ). In the MTSV1-7/tnp20 clone, cell scattering was evident also in untreated cells, but signi®cantly increased upon NGF treatment.
The morphological observations suggested that in the low-expressing HB2/tnp26 transfectant, proliferation in collagen was stimulated by NGF-induced receptor homodimerization, whereas in high-expressing clones, the net eect of NGF was inhibitory. This was con®rmed by MTS proliferation assay of cells growth in collagen (Figure 3 ). A comparison with Figure 1a shows that in the HB2 transfectants, proliferation upon NGF treatment was inversely correlated to the level of trk-neu expression. On plastic, the changes in proliferation induced by NGF were similar, but generally less pronounced (data not shown).
In the clones HB2/tnp38 and HB2/tnz34, cell scattering in collagen was accompanied by the appearance of apparently nonviable cells surrounded by cell fragments (Figure 4a ). This observation, together with the reduced proliferation seen in these clones (Figure 3 ) raised the possibility that the morphogenetic events induced by trk-neu homodimerization was accompanied by an apoptotic response. In situ¯uorescent TUNEL assay of cells grown in collagen was therefore performed on these cell lines, showing a dramatic increase in the frequency of stained nuclei in NGF-treated cells (Figure 4b and quantitated in Figure 7b ). Apoptosis, which was also determined by assaying fragmented morphology of propidium iodide-stained nuclei (data not shown), was strongly associated with the NGF-induced scattered morphology whereas untreated cells growing in coherent colonies were rarely stained. It should be noted that the quantitation of TUNEL-stained cells had to be performed after only 4 days of culture since the clustered growth of untreated cells prevented accurate counting of nuclei in larger colonies. Judging from the morphological observations, the apoptotic response would be expected to become more pronounced when the cells were grown for a longer time.
Expression of integrins and E-cadherin in trk-neu transfectants
The a 2 b 1 integrin is the major collagen binding integrin in HB2 and MTSV1-7 cells (Berdichevsky et al., 1994a) , and the response of HB2 cells in collagen to morphogenetic stimuli has been shown to be modulated by antibodies that modify the function of the a 2 b 1 integrin (Alford et al., 1998; Berdichevsky et al., 1994a) . Constitutive overexpression of c-erbB2 in MTSV1-7 cells has been shown to be associated with scattered colony morphology and downregulation of the expression of integrin a 2 as well as E-cadherin (D'Souza et al., 1993; D'Souza and Taylor-Papadimitriou, 1994) . Furthermore, promoter activity analyses have indicated that c-erbB2 overexpression can downregulate the transcription of integrin a 2 in a Rasdependent manner (Ye et al., 1996) . It was therefore of interest to elucidate the eect of induced c-erbB2 homodimer signalling in the trk-neu transfectants on integrin and E-cadherin expression. In Western blots of trk-neu transfectants grown for 1 week on plastic or collagen in the presence or absence of NGF, no major dierence in expression of the integrins a 2 , a 3 or b 1 or of E-cadherin could be detected, as exempli®ed in Figure 5a (a 3 not shown) with the clone HB2/tnz34 which displays the most dramatic morphological reaction to NGF treatment. Moreover, by indirect immuno¯uorescent staining of cells grown in collagen, it could be shown that the cell scattering induced by NGF in HB2/tnz34 cells was not accompanied by any major downregulation of integrin a 2 ( Figure 5b) ; similar results were obtained with integrin b 1 and Ecadherin (not shown). These results indicate that shortterm c-erbB2 signalling via activation of the trk-neu hybrid cannot signi®cantly reduce the expression of these adhesion molecules on the protein level. In addition to the short-term experiments, measurements were also made on transfectants kept for 10 passages in NGF, also without detectable changes in the overall levels of integrins a 2 or b 1 (data not shown).
Reversal of NGF-induced scattering and apoptosis by activation of the a 2 b 1 integrin
The morphological changes in NGF-treated trk-neu transfectants in collagen strongly indicated that the induced c-erbB2 homodimer signalling aected cellcollagen interactions. On the other hand, no signi®cant changes in the levels of collagen-binding integrins could be detected (the a 1 integrin is not expressed by HB2 cells (Berdichevsky et al., 1994a) ). These observations raised the possibility that the function of the integrins, rather than their abundance, was being modulated by the cerbB2 signalling. In order to test this hypothesis, HB2/ tnp38 and HB2/tnz34 cells were treated (in the presence or absence of NGF) with antibodies that modulate the activity of the a 2 b 1 integrin: TS2/16, which is a welldocumented activator of the b 1 subunit (van de Wiel-van Kemenade et al., 1992) ; HAS4 (Tenchini et al., 1993) , which binds the a 2 subunit and has been shown to possess some features of an integrin-activating antibody (such as decreasing cell motility on collagen and inhibiting HGF-induced morphogenesis (Alford et al., 1998) ); and P5D2 and P1E6, which block the ligand- binding capacity of integrins b 1 and a 2 , respectively. Both the activating antibodies were able to inhibit NGFinduced cell scattering in collagen ( Figure 6 ); moreover, the apoptotic response and the decrease in proliferation seen in NGF-treated transfectants were both completely reversed in the presence of these antibodies ( Figure 7 ). Since the integrin-activating antibodies stimulated proliferation also in the NGF-untreated transfectants, one may assume that the background phosphorylation observed ( Figure 1B ) confers some degree of integrin inactivation also in the absence of NGF. In contrast, the blocking antibodies P1E6 and P5D2 did not aect the NGF-induced scattering, ( Figure 6 ); instead, it exacerbated the proliferative decrease ( Figure 7a [only P5D2 shown]) and apoptosis (not shown) displayed by the NGF-treated transfectants.
These results suggest that the internal signals generated by phosphorylation of the c-erbB2 receptor aect the conformation of the a 2 b 1 integrin and thus the functional interaction of the cells with the collagen matrix, an interaction which is necessary for cell survival.
c-erbB2 homodimer signalling and heregulin treatment elicit distinct responses in HB2/tnz34 cells
In a previous paper (BaeckstroÈ m et al., 2000) we have described how the growth factor heregulin induces striking morphogenesis and stimulates proliferation in HB2 cells grown in collagen, and that these responses are dependent on c-erbB2 as well as c-erbB3 (most likely as a result of heregulin-induced c-erbB2/c-erbB3 . It was therefore of interest to analyse the eect of heregulin on trk-neu transfectants in which the NGF-induced c-erbB2 homodimer signalling led to a proliferative decrease. As shown in Figure  8 , heregulin treatment of HB2/tnz34 cells elicits an increase in proliferation and a spiky colony morphology neither of which is as pronounced as in heregulin treated parental HB2 cells; however, they are in sharp contrast to the scattering and loss of viability seen upon NGF treatment. This result strengthens the conclusion that c-erbB2 homodimerization and heregulin-induced c-erbB2/c-erbB3 heterodimerization can give rise to widely distinct biological eects.
Phenotypic changes in trk-neu transfectants following prolonged NGF treatment
As related above, when the HB2/tnp26 and HB2/tnp38 transfectants were grown for 10 passages or more in the presence of NGF, no changes in cell morphology could be detected. However, in the case of the highexpressing HB2/tnz34 and the MTSV1-7/tnp20 transfectants, treatment of the cells with 50 ng/ml NGF for several passages led to the emergence of an increasing frequency of ®broblastic cells interspersed with the dominating epithelial phenotype as shown for MTSV1-7/tnp20 cells in Figure 9a . Immuno¯uorescent staining for intermediate ®lament components of this cell mixture revealed that the ®broblastic cells had acquired expression of the mesenchymal marker vimentin, whereas the epithelial marker keratin 18 was variably downregulated (Figure 9b ,c).
In order to further analyse the properties of the cells in later passages, ®broblastic and epithelial sub-clones were isolated from MTSV1-7/tnp20 cells that had been treated with NGF for 10 passages and the expression of integrins a 2 and b 1 , E-cadherin and the trk-neu hybrid were determined by Western blot analysis. As exempli®ed in Figure 10 , the ®broblastic subclones were characterized by strong reductions in the levels of integrin a 2 and E-cadherin. Furthermore, the overall expression level of the trk-neu construct was higher in the ®broblastic than in the epithelial subclones or in the progenitor MTSV1-7/tnp20 cells, indicating that the ®broblastic cells had originated from the most highly-expressing subpopulations within these transfectants. The ®broblastic cells were also characterized by a low growth rate which was further reduced upon NGF treatment (Figure 11a ). This eect was especially pronounced in collagen, where a very high frequency of apoptotic cells was observed (Figure 11b) . In contrast to the behaviour of NGF-treated HB2/tnp38 or HB2/tnz34 cells (Figure 6 ), the impaired growth and frequent apoptosis of these cells could not be ameliorated by treatment with integrin-activating antibodies (data not shown). Epithelial subclones, although morphologically indistinguishable from the progenitor MTSV1-7/tnp20 cells both on plastic and in collagen (data not shown), displayed a minor reduction in growth rate suggesting that a more subtle phenotypic change had occurred in these cells as a result of prolonged NGF treatment.
Anchorage-independent growth of trk-neu transfectants
Anchorage-independent growth assayed by colony formation in soft agar is closely linked to a malignant phenotype and has been reported to result from cerbB2 overexpression in mammary epithelial cells (D'Souza et al., 1993; Sheeld, 1998) . When plated in soft agar, none of the trk-neu transfectants (including the ®broblastic subclones from MTSV1-7/ tnp20 cells) showed any growth with the exception of HB2/tnz34 (Table 1) , where colony formation was doubled upon NGF treatment. Since HB2/tnz34 is the most high-expressing of the trk-neu transfectant clones described here, these results suggest a critical threshold of c-erbB2 signalling below which anchorage-independent growth cannot occur.
Discussion
Overexpression of the type I tyrosine kinase receptor cerbB2 has been implicated in the aetiology of mammary carcinoma and agents that interfere with its function are being evaluated for their therapeutic potential in the treatment of breast cancer (Shak, 1999) . The immediate signalling eect of c-erbB2 overexpression is generally believed to be ligand-independent homodimerization leading to continuous activation of the dimerization partners' tyrosine kinase domains. In the present investigation, we have attempted to analyse the relationship between this signalling event and conversion of cell phenotype on dierent time scales using an inducible Figure 5 In¯uence of NGF treatment on integrin and E-cadherin expression in the trk-neu transfectant clone HB2/tnz34. (a) Western blot analysis for the expression of a 2 or b 1 integrins and E-cadherin following treatment with 50 ng/ml NGF for 1 week. Controls and NGF-treated cells were grown for 7 days on plastic before lysis, separation of proteins on 6% SDS ± PAGE and transfer to PVDF membranes. All samples were reduced except for in the b 1 integrin blot. (b) Expression of integrin a 2 in HB2/ tnz34 cells grown in collagen for 1 week in the absence or presence of 50 ng/ml NGF as measured by immuno¯uorescence microscopy. The micrographs show representative colonies stained in the collagen gel with the antibody HAS4 directed against the a 2 integrin subunit. In order to preferentially stain extracellular integrins, cells were not permeabilized in these samples Oncogene c-erbB2 homodimerization in mammary epithelial cells D Baeckstro Èm et al system, the`trk-neu' hybrid receptor. In trk-neu transfected cells, homodimerization of the c-erbB2 cytoplasmic domain can be initiated and interrupted by the addition and removal of NGF, respectively. The development of human mammary epithelial cell lines expressing the trk-neu receptor has also allowed the analysis of the eect of increasing the signals from the cerbB2 homodimer on the behavioural properties of these cells without prejudicing the eects towards stimulation of cell growth.
The data obtained with the trk-neu transfectants indicate that modest levels of expression of the receptor, and therefore of signals generated on addition of the NGF ligand, do indeed result in a stimulation of cell growth. However, where the intensity of the signals is increased, in the HB2 clones expressing higher levels of the receptor, short term (4 ± 7 days) treatment with NGF induces colony disruption and growth inhibition. This eect is seen when cells are grown in a collagen matrix, where the cell ± matrix interaction and survival of these cells depend on the expression and function of the a 2 b 1 integrin (Alford et al., 1998; Berdichevsky et al., 1994a) . Although the level of the a 2 b 1 integrin was not reduced by short term treatment with NGF, the function of the integrin appeared to be impaired. This can be deduced from the observation that the negative eects of NGF on colony morphology and cell proliferation in collagen of the high expressing clones could be reversed by treatment with antibodies which activate the a 2 b 1 integrin. Furthermore, the morphology of scattered NGF-treated transfectants closely resembled that of parental HB2 cells treated with sub-lethal doses of blocking antibodies to the a 2 or b 1 integrin subunits (Alford et al., 1998; Berdichevsky et al., 1994a) . These ®ndings strongly indicate that Figure 7 Proliferation (a) and apoptosis (b) in collagen of highexpressing HB2/trk-neu transfectants in response to NGF and antibodies to the integrin subunits a 2 and b 1 . Single-cell suspensions of the cells were incubated with the antibodies indicated before embedding in collagen and culture in the absence or presence of NGF. In the proliferation assay (a), HB2/tnp38 cells were grown for 7 days before addition of the MTS reagent. Fold changes in HB2 cell proliferation were calculated relative to antibody-untreated HB2 cells and changes in HB2/tnp38 cell proliferation were calculated relative to antibody-and NGFuntreated HB2/tnp38 cells. In the apoptosis assay (b), HB2/tnz34 cells were grown for 4 days before ®xation and staining for apoptotic nuclei using the TUNEL method. The antibodies are: HAS4 against the a 2 subunit which is a putative activator of ligand binding; P1E6, an inactivating a 2 antibody; TS2/16, an activating b 1 antibody and P5D2, an inactivating b 1 antibody c-erbB2 homodimerization in mammary epithelial cells D Baeckstro Èm et al signalling from the c-erbB2 homodimer can negatively regulate the function of the a 2 b 1 integrin, leading to decreased viability. One possible mechanism for this regulation is suggested by the results of Lo et al. (1999) who found enhanced interaction between focal adhesion kinase and paxillin in NIH3T3 cells upon c-erbB2-transfection. An antagonism between sustained c-erbB2 signalling and integrin-mediated matrix adhesion is also suggested by the results of Tagliabue et al. (1996) who observed laminin-dependent complex formation between c-erbB2 and the a 6 b 4 integrin, leading to surface downregulation of c-erbB2 and growth inhibition. However, as the present results show, the outcome of c-erbB2 signalling is highly dose-dependent and also likely to be strongly in¯uenced by the cell type. In this context, it is interesting to note that the in¯uence of EGF on integrin expression and function has been reported to be either positive or negative depending on the degree of receptor expression (Genersch et al., 1996; Krensel and Lichtner, 1999) . When NGF treatment of high-expressing trk-neu transfectants was extended to a period of several weeks, subpopulations appeared which displayed a ®broblastic morphology, vimentin expression and loss of E-cadherin and integrin a 2 . In ®broblastic clones isolated from MTSV1-7/tnp20 cells, the expression ( Figure 10 ) and tyrosine phosphorylation (not shown) of the trk-neu hybrid was signi®cantly higher than in the epithelial transfectants from which they originated. It thus appears that in the MTSV1-7/tnp20 cells that had the highest degree of trk-neu expression, prolonged NGF-induced signalling exceeded a critical threshold level where gain of ®broblastic phenotype and loss of epithelial markers appeared more or less simultaneously.
Epithelial-mesenchymal conversion has earlier been observed as a result of constitutive overexpression of full-length c-erbB2 in MTSV1-7 cells (D'Souza et al., 1993; D'Souza and Taylor-Papadimitriou, 1994 ). The resulting cell line, ce1, also displayed decreased levels of E-cadherin and integrin a 2 . In addition, the ce1 cells had acquired anchorage-independent growth and tumorigenicity as assayed by growth in soft agar and tumour formation in mice, respectively. Other studies have also reported these changes in c-erbB2 overexpressing mammary epithelial cells (Baasner et al., 1996; Sheeld, 1998) . However, none of the ®bro-blastic clones derived from the MTSV1-7/tnp20 cells grew in soft agar, regardless of NGF treatment. The same behaviour was also found in the other trk-neu transfectants with the exception of HB2/tnz34 cells where a modest, but NGF-enhanced colony frequency was observed. One may thus conclude from the present data that although the conversion to a ®broblastic phenotype is closely linked to downregulation of integrin a 2 and E-cadherin, it is not necessarily linked to anchorage independence. Nowak et al. (1997) have proposed that only very high levels of c-erbB2 signalling will confer a fully malignant phenotype, and this hypothesis could explain the discrepancy in phenotype between ce1 cells and the trk-neu transfectants, since the expression of c-erbB2 in ce1 cells is higher than trk-neu expression in any of the transfectants described here (as measured in Western blots using the 21N antiserum, data not shown). The signalling pathway leading from c-erbB2 signalling to anchorage independence is likely be dependent on both c-src and PI(3)-kinase, since inhibition of either has been shown to block growth in soft agar of c-erbB2-transfected mammary epithelial cells (Ignatoski et al., 2000; Sheeld, 1998) .
The response to c-erbB2 homodimer signalling described here does not appear to be a general eect of activation EGF receptor family members, as treatment of HB2/tnz34 cells with the growth factor heregulin, which requires the participation of c-erbB3 and/or c-erbB4 in functional receptor heterodimers, resulted in compact colony morphology and proliferative stimulation in collagen, a phenotype widely dierent from that seen upon NGF treatment. Since all available data strongly indicate that the c-erbB2/cerbB3 heterodimer is the major heregulin receptor in epithelial cells, including HB2 cells (BaeckstroÈ m et al., 2000) , one may conclude that the signalling molecules recruited by the c-erbB2/c-erbB3 heterodimer are dierent from those recruited by the c-erbB2 homodimer (Khwaja et al., 1997) One possible mediator of such signalling which could be recruited dierently could be PI(3)-kinase, which is known to promote cell survival under conditions of matrix deprivation (Khwaja et al., 1997) and which is much more eciently recruited by c-erbB3 than by c-erbB2. Other recent studies have showed dierences in the in¯uence on adhesive and proliferative properties between dierent EGF receptor dimers. Also using arti®cial dimerization of receptor hybrids, Muthuswamy et al. (1999) showed a strikingly higher focus-forming ability in rat ®broblasts upon c-erbB2 homodimerization compared to heterodimerization between c-erbB2 and the EGF receptor. Adelsman et al. (1999) have Figure 9 Morphology and intermediate ®lament expression of MTSV1-7/tnp20 transfectants after prolonged NGF treatment. The phase-contrast image (a) shows the mixed morphology resulting from NGF treatment of this transfectant: groups of coherently growing epithelial cells (left) typical of the original MTSV1-7/tnp20 transfectant clone were interspersed with scattered cells of ®broblastic morphology (right). In the immunouorescence micrographs (b, c), the cells have been probed with antibodies against keratin 18 (b) or vimentin (c) followed by FITC-labelled secondary antibody (green) and nuclear counterstaining with propidium iodide (red). Dense clusters of epithelial cells were strongly stained with the keratin 18 antibody, whereas the scattered ®broblastic cells mostly displayed weak or no staining (b). The reverse is true for the vimentin staining (c). All scale bars=100 mm Figure 10 Analysis of the expression of integrin a 2 , E-cadherin and the trk-neu hybrid (as detected by the 21N antiserum against the c-erbB2 cytoplasmic domain) by Western blot in MTSV1-7/ tnp20 cells and representative epithelial and ®broblastic subclones obtained after prolonged NGF treatment. The control transfectant MTSV1-7/puro mix is included for comparison. E, epithelial phenotype; F, ®broblastic. Lysates were separated on a 6% SDS ± PAGE gel before transfer to PVDF membranes c-erbB2 homodimerization in mammary epithelial cells D Baeckstro Èm et al observed a marked dierence between EGF and heregulin-b in their capacity to stimulate b 1 integrin function in mammary carcinoma cells. Since c-erbB2 has been shown to be a preferred heterodimerization partner for the other EGF receptor family members (Graus-Porta et al., 1997) , it is evident that dierences in the heterodimerization partners' substrate domains and their accessibility to docking proteins strongly modulate the biological eects of c-erbB2 activation. Taking together the phenotypical responses of MTSV1-7 and HB2 cells to inducible c-erbB2 homodimerization, one can conclude that c-erbB2 signalling negatively aects cell-collagen interaction in mammary epithelial cells both by aecting integrin function and expression. These anti-adhesive eects would be advantageous to carcinoma cells by promoting tissue disruption and invasive behaviour. However, c-erbB2-induced adhesion downregulation does not appear to be automatically linked to protection against the apoptotic response that follows loss of functional matrix contact in epithelial cells; rather, c-erbB2 signalling must exceed a critical threshold level for such protection to occur. This conclusion would oer one explanation to the often reported phenomenon that tumour development is frequently accompanied by increased apoptosis (Naik et al., 1996; Soini et al., 1998) . A cell embarking on a tumorigenic pathway by overexpressing c-erbB2 would thus have to pass a bottleneck in viability until either the level of c-erbB2 signalling becomes high enough or some other phenotypic or genotypic change occurs to prevent anoikis; during this interval, an increase in the generation of apoptotic cells would be expected.
Materials and methods
Growth factors and antibodies
NGF from mouse submaxillary gland was purchased from Promega. Recombinant human heregulin b1 177 ± 244 , a fragment (M r =7884) containing the receptor-binding EGF-like domain was a gift generously provided by Dr MX Sliwkowski, Genentech, South San Francisco, CA, USA. The monoclonal antibodies (mAbs) TS2/16 and P5D2 which activate and suppress the binding capacity of integrin b 1 , respectively, were prepared from hybridoma cells available from ATCC. The mAb HAS4 against integrin a 2 was a gift generously provided by Dr Fiona Watt, Imperial Cancer Research Fund, London UK. The rabbit antisera AB1936 and AB1920 against integrins a 2 and a 3 , respectively, as well as the function-blocking integrin a 2 mAb P1E6 (MAB1950) were purchased from Chemicon. The 21N rabbit antiserum against a region in the cytoplasmic domain of c-erbB2 was obtained from NeoMarkers. The anti-vimentin mAb Vim3B4 was purchased from DAKO. For the detection of keratin 18, the mAb Da7 (Lauerova et al., 1988) was used. Phosphotyrosine was detected using the mAb 4G10 from Upstate Biomedical. The mAb HECD-1 against E-cadherin was purchased from Takara Biomedicals.
Expression vectors
The pBATtrk-neu vector was a gift generously supplied by Drs Martin Sachs and Walter Birchmeier of the Max Planck- Institut, Berlin, Germany. The pcDNA3.1zeo/trk-neu plasmid was generated by excision of the trk-neu cDNA using SalI and cloning into the XhoI site of pcDNA3.1zeo+ (Invitrogen).
Cell culture The cell lines MTSV1-7 (Bartek et al., 1991) and HB2 (Berdichevsky et al., 1994a) , derived from human mammary epithelial cells obtained from mothers' milk, were cultured in DMEM supplemented with 10% foetal calf serum (FCS), 5 mg/ml hydrocortisone and 10 mg/ml insulin. Transfectants carrying puromycin or zeocin resistance genes were grown in the presence of 0.5 mg/ml puromycin or 5 mg/ml zeocin, respectively. Cell culture in collagen was performed by suspending single cells in a neutralized solution of bovine dermal collagen I (Vitrogen 100, Collagen Biomaterials) to a ®nal cell concentration of 10 4 cells/ml and dispensing 100 ml of suspension/well in 96-well plates. Cells were allowed to set at 378C for 90 ± 120 min during which time the plates were inverted every 15 min to ensure an even distribution of cells within the collagen gel. The wells were then fed 200 ml regular growth medium and refed after 24 h with 100 ml medium containing growth factors, antibodies etc. where applicable.
Transfections
MTSV1-7 and HB2 cells were transfected with trk-neucontaining vectors by means of calcium phosphate-DNA coprecipitation using standard techniques (Sambrook et al., 1989) . Resistant clones were isolated by ring cloning and tested for expression of the c-erbB2 cytoplasmic domain in immuno¯uorescent staining, NGF-induced morphogenesis in collagen and tyrosine phosphorylation.
Proliferation assays
Cells were plated from a single cell suspension into 96-well plates (for plating of cells in collagen, see`Cell culture'). After having grown for the required time period, 20 ml/well of MTS reagent (CellTiter96 AQueous One Solution Proliferation Assay, Promega) was added to each well. Absorbance at 450 nm was read after 2 ± 5 h and the net absorbance was calculated from triplicate data points after subtraction of blank absorbance (medium only or collagen+medium only). The linearity of the assay at the cell densities used was veri®ed in separate experiments.
Soft agar assay
Cells were plated at 350 cells/well in 24-well plates in 0.3% agar on top of a 0.5% agar base. Both agar layers contained DMEM with supplements as described above. Two days after plating, 1 ml medium (with or without 50 ng/ml NGF) was added to each well. After 2 weeks in culture, colony formation was evaluated by counting the frequency of colonies containing more than 10 cells. The breast cancer cell line T47D was used as a positive control.
In-gel apoptosis assays
Apoptotic nuclei of cells grown in collagen were stained by a modi®ed version of the terminal dUTP nick-end labelling (TUNEL) protocol (Apoptosis Detection System, Fluorescein, Promega). Brie¯y, cells were grown in collagen in 96-well plates as described above, the medium was replaced with cold 4% paraformaldehyde in PBS and the ®xation was allowed to proceed for 2 h on ice before removing the cellcontaining collagen plugs from the plates using a 23-gauge needle (®xation before removing the plugs ensured excellent preservation of colony morphology). The plugs were then washed and stained according to the manufacturer's description but all incubation times were doubled and reagent volumes were scaled up to allow covering of the plug. After TUNEL reaction and propidium iodide (PI) counterstaining, plugs were immersed in 10 mM tris-HCl, pH 8.0, 50% glycerol for 1 h and then put inside a ring of silicone rubber on a glass slide and overlayed with a cover glass. Light pressure was applied to the cover glass to reduce the sample thickness and the silicone rubber was allowed to set before viewing. The frequency of apoptotic cells was evaluated as the ratio of TUNEL-stained nuclei (FITC¯uorescence) to all nuclei (PI¯uorescence) in three random ®elds/plug in triplicate, giving a minimum nucleus count of 300/data point.
Immunofluorescence microscopy
For analysis of cells grown on plastic, cells were plated in 35-mm tissue culture dishes at low density (2000 cells/dish) and allowed to grow for 1 week. The cells were then ®xed in cold (7208C) methanol for 5 min. After three washes with PBS, the dishes were incubated with 20% FCS in PBS for 1 h followed by an incubation with monoclonal antibodies against vimentin or keratin 18 for 1 h. After three washes with PBS,¯uorescein-conjugated rabbit anti-mouse immunoglobulin (DAKO, dilution 1/50 in PBS with 5% FCS) was added. After 1 h, the dishes were washed once with PBS containing 5 mg/ml propidium iodide and twice with PBS. Before viewing under a¯uorescence microscope, 100 ml of 10 mM tris-HCl, pH 8.0, 50% glycerol was added and a 32 mm circular coverglass was placed over the cells.
Cells grown in collagen in 96-well plates were ®xed, washed and mounted as described above for the TUNEL apoptosis assay. In some analyses, permeabilization with Triton X-100 was omitted.
Western blot
Lysates were prepared from cells grown to 80 ± 90% con¯uence in 6-cm dishes on plastic or a layer of 500 ml polymerized collagen I. Cells were washed three times with PBS before lysis in 50 mM tris-HCl, pH 7.5, 0.15 M NaCl, 1% Triton X-100, 5 mM EDTA, 0.5 mM phenylmethyl sulphonyl¯uoride, 100 KIE/ml aprotinin, 50 mg/ml leupeptin. In phosphotyrosine analyses, cells were kept with serum-free medium 8 ± 16 h before stimulation and washed and lysed in the presence of 1 mM Na 3 VO 4 .
The protein concentrations of the lysates were determined using the BCA protein assay (Pierce) and equal amounts of protein for each sample were loaded onto 6% SDS ± PAGE gels. For the analysis of E-cadherin and integrin a 2 , the samples were reduced, whereas unreduced samples were used for the analysis of integrin b 1 . The separated proteins were transferred to PVDF membranes (Hybond-P, Amersham Pharmacia) by electroblotting at 3 mA/cm 2 for 2 h in 25 mM tris, 0.192 M glycine, 20% methanol. The membranes were blocked in PBS with 5% nonfat dry milk, 0.1% Tween-20. Membranes were then incubated with primary antibody diluted in blocking solution. Membranes were washed in PBS, 0.1% Tween-20 and bound antibodies were detected using horseradish peroxidase-conjugated secondary antibodies in combination with the Enhanced Chemiluminescence (ECL) system (Amersham Pharmacia).
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